Dr. Roland Graf focuses his practice on biotech and pharma patents, involving technical fields such as small molecule cancer therapeutics, antibodies, and enzyme replacement therapies. In addition to patent drafting, prosecution, opposition, and appeal proceedings, Roland has particular experience in creating Supplementary Protection Certificate portfolios covering the majority of European jurisdictions. He also has experience in vindication proceedings and German compulsory license proceedings. Prior to joining Jones Day in 2011, Roland worked in the biotechnology group of a German intellectual property firm located in Stuttgart.Roland is a molecular biologist by training, but he has worked in other scientific disciplines including structural biology, biochemistry, and immunology. Roland’s masters and doctoral theses, which he obtained at the International Max Planck Research School for Molecular Biology, involved molecular aspects of aberrant cell migration in the Drosophila model. His broad scientific background gives him a deep understanding of both the analytical and medical aspects of pharmaceutical research. In addition, he has experience in the field of medical technology including endoluminal prostheses, such as stents and artificial heart valves, as well as retina-implants.